1. Response, toxicity, and pharmacokinetics of high dose methotrexate (NSC-740) with citrovorum factor (NSC-3590) in osteogenic sarcoma;Pratt;Cancer Chemother Rep (Part 3),1975
2. Clinical trials and pharmacokinetics of intermittent high dose methotrexate leucovorin rescue for children with malignant tumors;Pratt;Cancer Res,1974
3. Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma;Rosen;Cancer,1976
4. “Adjuvant” high dose methotrexate and citrovorum rescue (HDMC) following primary treatment of osteogenic sarcoma;Jaffe,1974
5. Multidrug chemotherapy in primary treatment of osteosarcoma. An editorial commentary;Jaffe;J Bone Joint Surg,1976